Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in …
K Ogawa, H Morito, A Hasegawa, N Daikoku… - Journal of …, 2013 - Elsevier
BACKGROUND: Drug-induced hypersensitivity syndrome (DIHS)/drug rash with
eosinophilia and systemic symptoms (DRESS) is a serious acute drug reaction with fever …
eosinophilia and systemic symptoms (DRESS) is a serious acute drug reaction with fever …
Drugs and the skin: A concise review of cutaneous adverse drug reactions
BR Del Pozzo‐Magaña… - British Journal of Clinical …, 2022 - Wiley Online Library
Drug‐induced skin disease or cutaneous adverse drug reactions (CADRs) are terms that
encompass the clinical manifestations of the skin, mucosae and adnexa induced by a drug …
encompass the clinical manifestations of the skin, mucosae and adnexa induced by a drug …
[HTML][HTML] Anticancer drugs induced severe adverse cutaneous drug reactions: an updated review on the risks associated with anticancer targeted therapy or …
CY Ng, CB Chen, MY Wu, J Wu, CH Yang… - Journal of immunology …, 2018 - hindawi.com
Cutaneous adverse drug reactions are commonly seen in patients with anticancer drug
treatment. Anticancer drugs, including chemotherapy, target therapy, and recent …
treatment. Anticancer drugs, including chemotherapy, target therapy, and recent …
Drug reaction with eosinophilia and systemic symptoms: an update and review of recent literature
A De, M Rajagopalan, A Sarda, S Das… - Indian journal of …, 2018 - journals.lww.com
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, is also known
as drug induced hypersensitivity syndrome and by various other names. It is now recognised …
as drug induced hypersensitivity syndrome and by various other names. It is now recognised …
Drug reaction with eosinophilia and systemic symptoms (DReSS)/Drug-Induced hypersensitivity syndrome (DiHS)—readdressing the DReSS
H Stirton, NH Shear, RP Dodiuk-Gad - Biomedicines, 2022 - mdpi.com
Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-
induced hypersensitivity syndrome (DiHS), is a severe, systemic, T cell mediated drug …
induced hypersensitivity syndrome (DiHS), is a severe, systemic, T cell mediated drug …
Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis
N Hama, R Abe, A Gibson, EJ Phillips - The Journal of Allergy and Clinical …, 2022 - Elsevier
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic
symptoms (DIHS/DRESS) is one example of a severe delayed T-cell–mediated adverse …
symptoms (DIHS/DRESS) is one example of a severe delayed T-cell–mediated adverse …
Short-and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution
Y Ushigome, Y Kano, T Ishida, K Hirahara… - Journal of the American …, 2013 - Elsevier
BACKGROUND: Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with
eosinophilia and systemic symptoms (DRESS) is a severe systemic hypersensitivity reaction …
eosinophilia and systemic symptoms (DRESS) is a severe systemic hypersensitivity reaction …
[HTML][HTML] The epidermis as an adjuvant
D Gutowska-Owsiak, GS Ogg - Journal of investigative dermatology, 2012 - Elsevier
It is now clear that the epidermis has an active role in local immune responses in the skin.
Keratinocytes are involved early in inflammation by providing first-line innate mechanisms …
Keratinocytes are involved early in inflammation by providing first-line innate mechanisms …
Cellular and molecular pathophysiology of cutaneous drug reactions
WJ Pichler, N Yawalkar, M Britschgi, J Depta… - American journal of …, 2002 - Springer
Hypersensitivity reactions to drugs can cause a variety of skin diseases like maculopapular,
bullous and pustular eruptions. In recent years increasing evidence indicates the important …
bullous and pustular eruptions. In recent years increasing evidence indicates the important …
T lymphocytes attenuate dermal scarring by regulating inflammation, neovascularization, and extracellular matrix remodeling
Objective: While tissue injury and repair are known to involve adaptive immunity, the profile
of lymphocytes involved and their contribution to dermal scarring remain unclear. We …
of lymphocytes involved and their contribution to dermal scarring remain unclear. We …